Menu
Next generation skin
Menu
About the company
Synflora, a research project in the process of being established as a biotech start-up, focuses on studying the human skin microbiome to enhance human health. The human body hosts trillions of microorganisms that interact closely with our cells. We regard the microbiome as an extension of the human host. By integrating its natural capabilities with innovative technologies based on proteins or siRNAs, we aim to develop exclusive treatments for skin conditions.
Technology Skin 2.0
Synflora represents a platform based on engineered skin microbes capable of improving skin health by producing and secreting continuous active molecules within the hair follicle overcoming invasive treatments and low penetration. Synflora is able to produce and deliver therapeutics long term within the skin while being precise and targeted to the site of interest. Our technology enables the treatment of skin conditions by harnessing nature’s capabilities and precise genetic engineering efforts.
Team
Marc Güell Cargol, PhD
Tenure Track Professor and Principal Investigator.
Co-Founder and Scientific Head.
marc.guell@upf.edu
Nastassia Knödlseder, PhD
CEO and co-founder.
Post-doctoral researcher.
nastassia.knoedlseder@upf.edu
News
Publications
1. Knödlseder, N.J, et al., Delivery of a sebum modulator by an engineered skin microbe in mice. Nature Biotechonology. 2024. DOI: doi.org/10.1038/s41587-023-02072-4
Dr. Aiguader, 88
Barcelona Biomedical Research Park
08003 Barcelona (Spain)